Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

MERCK vs PFIZER - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More


Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More


Current Valuations

P/E (TTM) x 51.6 34.8 148.2% View Chart
P/BV x 9.0 5.5 163.9% View Chart
Dividend Yield % 0.4 0.6 60.8%  


5-Yr Chart
Click to enlarge
High Rs1,3582,365 57.4%   
Low Rs9331,625 57.4%   
Sales per share (Unadj.) Rs665.0430.3 154.6%  
Earnings per share (Unadj.) Rs56.678.7 71.9%  
Cash flow per share (Unadj.) Rs72.593.2 77.8%  
Dividends per share (Unadj.) Rs15.0020.00 75.0%  
Dividend yield (eoy) %1.31.0 130.6%  
Book value per share (Unadj.) Rs441.7586.5 75.3%  
Shares outstanding (eoy) m16.6045.75 36.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.6 37.1%   
Avg P/E ratio x20.225.3 79.9%  
P/CF ratio (eoy) x15.821.4 73.8%  
Price / Book Value ratio x2.63.4 76.2%  
Dividend payout %26.525.4 104.3%   
Avg Mkt Cap Rs m19,01191,271 20.8%   
No. of employees `0001.52.6 58.7%   
Total wages/salary Rs m1,6963,143 54.0%   
Avg. sales/employee Rs Th7,150.07,484.8 95.5%   
Avg. wages/employee Rs Th1,098.71,195.0 91.9%   
Avg. net profit/employee Rs Th608.21,369.1 44.4%   
Net Sales Rs m11,04019,685 56.1%  
Other income Rs m2401,143 21.0%   
Total revenues Rs m11,27920,828 54.2%   
Gross profit Rs m1,3765,003 27.5%  
Depreciation Rs m264663 39.8%   
Interest Rs m04 0.0%   
Profit before tax Rs m1,3525,479 24.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5831,878 31.0%   
Profit after tax Rs m9393,601 26.1%  
Gross profit margin %12.525.4 49.1%  
Effective tax rate %43.134.3 125.7%   
Net profit margin %8.518.3 46.5%  
Current assets Rs m7,52324,167 31.1%   
Current liabilities Rs m2,2539,544 23.6%   
Net working cap to sales %47.774.3 64.3%  
Current ratio x3.32.5 131.9%  
Inventory Days Days5255 94.7%  
Debtors Days Days4129 141.3%  
Net fixed assets Rs m1,2409,514 13.0%   
Share capital Rs m166458 36.3%   
"Free" reserves Rs m7,16726,375 27.2%   
Net worth Rs m7,33326,832 27.3%   
Long term debt Rs m025 0.0%   
Total assets Rs m9,91236,900 26.9%  
Interest coverage xNM1,305.5-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.5 208.8%   
Return on assets %9.59.8 97.0%  
Return on equity %12.813.4 95.4%  
Return on capital %20.820.4 101.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01522 4,529.5%   
Fx outflow Rs m3,0431,489 204.4%   
Net fx Rs m-2,028-1,466 138.3%   
From Operations Rs m5373,318 16.2%  
From Investments Rs m-476-2,383 20.0%  
From Financial Activity Rs m-220-1,104 19.9%  
Net Cashflow Rs m-160-169 94.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 63.9 81.1%  
Indian inst/Mut Fund % 18.2 7.5 242.7%  
FIIs % 1.0 4.9 20.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 23.7 122.8%  
Shareholders   28,591 85,207 33.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster


Compare MERCK With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Today's Market

Sensex and Nifty Open at Record Highs; Modi Takes Early Lead(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.8% while the Hang Seng is down 1.2%.

Related Views on News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


May 23, 2019 10:09 AM